bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 2, 2024
Abstract
Adipose
tissue
(AT)
is
an
essential
metabolic
and
endocrine
organ,
which
are
categorized
into
the
white
adipose
(WAT)
brown
(BAT),
as
well
beige
(BeAT)
that
derives
from
WAT
browning.
Notably,
extracellular
vesicles
(EVs),
especially
tissue-produced
EVs,
have
been
recognized
to
be
critical
players
in
multiple
physiological
pathophysiological
settings
provide
efficient
strategy
for
disease
treatment.
However,
little
known
about
BeAT-derived
EVs
(BeEVs).
In
this
study,
we
induced
BeEV
formation
by
cold
stimulation
extracted
three
kinds
of
AT
via
enzyme
digestion
combined
with
gradient
centrifugation.
The
isolated
BeEVs
possess
typical
morphological,
structural
marker
characteristics
EVs.
Proteomics
analysis
further
demonstrated
hold
a
distinct
protein
profile
while
enriched
regulatory
proteins.
Importantly,
systemic
injection
mice
improved
dysfunction
nonalcoholic
fatty
liver
(NAFLD)
model
high-fat
diet
(HFD).
Moreover,
alleviated
steatosis
decreasing
lipogenesis.
These
findings
promote
understanding
AT-EVs
shed
light
on
isolation,
identification
applications
potent
regulator
novel
remedy
diseases.
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
2(3)
Published: March 13, 2024
Abstract
Orthopedic
diseases,
such
as
osteoarthritis
and
fractures,
place
a
significant
burden
on
individuals
healthcare
systems
worldwide.
Extracellular
vesicles
(EVs),
which
are
membrane‐derived
particles,
have
emerged
novel
tool
in
the
field
of
orthopedics.
EVs
play
crucial
role
diagnosing,
regenerating,
treating
orthopedic
diseases.
In
terms
diagnosis,
serve
potential
biomarkers,
carrying
unique
donor
cell
information
circulating
effectively
bodily
fluids.
Specific
biomolecules
within
EVs,
including
proteins,
nucleic
acids,
microRNAs,
hold
promise
biological
markers
for
early
detection
monitoring
shown
promoting
bone
cartilage
regeneration.
They
can
enhance
tissue
regeneration
by
stimulating
various
stem
cells
to
proliferate,
migrate,
differentiate
into
mature
chondrocytes
osteocytes.
also
target
specific
tissues,
making
them
attractive
candidates
drug
delivery
efficiently
deliver
therapeutic
cargo,
anti‐inflammatory
agents
growth
factors,
affected
sites,
enhancing
treatment
efficacy
while
minimizing
toxicity
adverse
effects.
conclusion,
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(7)
Published: Feb. 14, 2024
Extracellular
vesicle
(EV)-based
immunotherapeutics
have
emerged
as
promising
strategy
for
treating
diseases,
and
thus,
a
better
understanding
of
the
factors
that
regulate
EV
secretion
function
can
provide
insights
into
developing
advanced
therapies.
Here,
we
report
nutrient
availability,
even
changes
in
individual
components,
may
affect
biogenesis
composition
immune
cells
[e.g.,
macrophages
(Mφs)].
As
proof
concept,
EVs
from
M1-Mφ
under
glutamine-depleted
conditions
(EV
Molecular Therapy,
Journal Year:
2024,
Volume and Issue:
32(9), P. 2950 - 2978
Published: June 22, 2024
Extracellular
vesicles
(EVs)
are
considered
a
vital
component
of
cell-to-cell
communication
and
represent
new
frontier
in
diagnostics
means
to
identify
pathways
for
therapeutic
intervention.
Recently,
studies
have
revealed
the
importance
tissue-derived
EVs
(Ti-EVs),
which
present
interstitial
spaces
between
cells,
as
they
better
underlying
physiology
complex,
multicellular
tissue
microenvironments
biology
disease.
native,
lipid
bilayer
membraned
nano-sized
particles
produced
by
all
cells
that
packaged
with
varied
functional
biomolecules
including
proteins,
lipids,
nucleic
acids.
They
implicated
short-
long-range
cellular
may
elicit
responses
recipient
cells.
To
date,
often
utilized
cultured
or
biological
fluids
source
do
not
capture
local
molecular
signatures
microenvironment.
Recent
work
utilizing
Ti-EVs
has
elucidated
novel
biomarkers
disease
provided
insights
into
mechanisms
lead
development
agents.
Still,
there
considerable
challenges
facing
current
studies.
This
review
explores
vast
potential
unique
Ti-EV
research
provides
considerations
future
seek
advance
this
exciting
field.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Aug. 30, 2024
Tissue-derived
extracellular
vesicles
(EVs)
are
emerging
as
pivotal
players
to
maintain
organ
homeostasis,
which
show
promise
a
next-generation
candidate
for
medical
use
with
extensive
source.
However,
the
detailed
function
and
therapeutic
potential
of
tissue
EVs
remain
insufficiently
studied.
Here,
through
bulk
single-cell
RNA
sequencing
analyses
combined
ultrastructural
examinations,
we
first
reveal
that
in
situ
liver
(LT-EVs)
contribute
intricate
regenerative
process
after
partial
hepatectomy
(PHx),
hepatocytes
primary
source
regenerating
liver.
Nanoscale
proteomic
profiling
further
identify
hepatocyte-specific
(Hep-EVs)
strengthened
release
carrying
proliferative
messages
PHx.
Moreover,
targeted
inhibition
Hep-EV
via
AAV-shRab27a
vivo
confirms
Hep-EVs
required
orchestrate
regeneration.
Mechanistically,
from
reciprocally
stimulate
hepatocyte
proliferation
by
promoting
cell
cycle
progression
Cyclin-dependent
kinase
1
(Cdk1)
activity.
Notably,
supplementing
demonstrates
translational
ameliorates
insufficient
This
study
provides
functional
mechanistic
framework
showing
governs
rapid
regeneration,
thereby
enriching
our
understanding
physiological
endogenous
regeneration
therapy.
Frontiers in Veterinary Science,
Journal Year:
2024,
Volume and Issue:
11
Published: Jan. 25, 2024
Extracellular
vesicles
are
nanoscale
that
transport
signals
between
cells,
mediating
both
physiological
and
pathological
processes.
EVs
facilitate
conserved
intercellular
communication.
By
transferring
bioactive
molecules
coordinate
systemic
responses,
regulating
homeostasis,
immunity,
disease
progression.
Given
their
biological
importance
involvement
in
pathogenesis,
show
promise
as
biomarkers
for
veterinary
diagnosis,
candidates
vaccine
production,
treatment
agents.
Additionally,
different
or
engineering
methods
could
be
used
to
boost
the
capability
of
extracellular
vesicles.
Despite
emerging
interest,
EV
research
has
been
predominantly
human-based.
Critical
knowledge
gaps
remain
regarding
isolation
protocols,
cargo
loading
mechanisms,
vivo
biodistribution,
species-specific
functions.
Standardized
characterization
validation
lacking.
Regulatory
uncertainties
impede
clinical
translation.
Advances
fundamental
biology
technology
needed
propel
field
forward.
This
review
introduces
from
a
perspective
by
introducing
latest
studies,
highlighting
potential
while
analyzing
challenges
motivate
expanded
investigation
Aging and Disease,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Although
significant
progress
has
been
made
in
early
lung
cancer
screening
over
the
past
decade,
it
remains
one
of
most
prevalent
and
deadliest
forms
worldwide.
Exosomal
proteomics
emerged
as
a
transformative
field
research,
with
potential
to
redefine
diagnostics,
prognostic
assessments,
therapeutic
strategies
through
lens
precision
medicine.
This
review
discusses
recent
advances
exosome-related
proteomic
glycoproteomic
technologies,
highlighting
their
revolutionise
treatment
by
addressing
issues
heterogeneity,
integrating
multiomics
data,
utilising
advanced
analytical
methods.
While
these
technologies
show
promise,
there
are
obstacles
overcome
before
they
can
be
widely
implemented,
such
need
for
standardization,
gaps
clinical
application,
importance
dynamic
monitoring.
Future
directions
should
aim
challenges
fully
utilize
exosomal
cancer.
promises
new
era
personalized
medicine
that
leverages
molecular
complexity
exosomes
groundbreaking
advancements
detection,
prognosis,
treatment.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2879 - 2879
Published: March 1, 2024
Neonatal
disorders,
particularly
those
resulting
from
prematurity,
pose
a
major
challenge
in
health
care
and
have
significant
impact
on
infant
mortality
long-term
child
health.
The
limitations
of
current
therapeutic
strategies
emphasize
the
need
for
innovative
treatments.
New
cell-free
technologies
utilizing
extracellular
vesicles
(EVs)
offer
compelling
opportunity
neonatal
therapy
by
harnessing
inherent
regenerative
capabilities
EVs.
These
nanoscale
particles,
secreted
variety
organisms
including
animals,
bacteria,
fungi
plants,
contain
repertoire
bioactive
molecules
with
potential.
This
review
aims
to
provide
comprehensive
assessment
effects
EVs
mechanistic
insights
into
stem
cells,
biological
fluids
non-animal
sources,
focus
common
conditions
such
as
hypoxic–ischemic
encephalopathy,
respiratory
distress
syndrome,
bronchopulmonary
dysplasia
necrotizing
enterocolitis.
summarizes
evidence
potential
EVs,
analyzes
their
mechanisms
action
discusses
challenges
associated
implementation
EV-based
therapies
clinical
practice.
Cells,
Journal Year:
2024,
Volume and Issue:
13(7), P. 623 - 623
Published: April 4, 2024
Limbal
epithelial
progenitor
cells
(LEPC)
rely
on
their
niche
environment
for
proper
functionality
and
self-renewal.
While
extracellular
vesicles
(EV),
specifically
small
EVs
(sEV),
have
been
proposed
to
support
LEPC
homeostasis,
data
sEV
derived
from
limbal
like
mesenchymal
stromal
(LMSC)
remain
limited,
there
are
no
studies
sEVs
melanocytes
(LM).
In
this
study,
we
isolated
conditioned
media
of
LMSC
LM
using
a
combination
tangential
flow
filtration
size
exclusion
chromatography
characterized
them
by
nanoparticle
tracking
analysis,
transmission
electron
microscopy,
Western
blot,
multiplex
bead
arrays,
quantitative
mass
spectrometry.
The
internalization
was
studied
cytometry
confocal
microscopy.
exhibited
typical
EV
characteristics,
including
cell-specific
markers
such
as
CD90
LMSC-sEV
Melan-A
LM-sEV.
Bioinformatics
analysis
the
proteomic
suggested
significant
role
in
matrix
deposition,
with
LMSC-derived
containing
proteins
involved
collagen
remodeling
cell
adhesion,
whereas
LM-sEV
were
implicated
other
cellular
bioprocesses
pigmentation
development.
Moreover,
fluorescently
labeled
taken
up
localized
perinuclear
compartment.
These
findings
provide
valuable
insights
into
complex
regulating
human
stem
niche.